Skip to content

Vertex Pharmaceuticals

US · VRTX #155 by market cap Listed 1970
515.02 -5.64 -1.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Vertex Pharmaceuticals

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Founded
1989
CEO
Dr. Reshma Kewalramani, M.D.
Employees
6,400
Headquarters
Boston, Massachusetts, United States of America
Fiscal year end
12-31
Website
vrtx.com

Company profile

Exchange
US
Symbol
VRTX
Market-cap rank
#155
Listing date
1970-01-01
Market cap
130.58B
Float cap
130.19B
Shares out
253.54M
Float shares
252.79M

Sectors & themes

Biotechnology ARK Portfolio Gene Editing Global medical industry Regular Savings Plan Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.

Vertex Pharmaceuticals discussion 0 comments

Add a comment